Dr. Takayuki Yoshino, M.D. PhD. currently works at the National Cancer Center Hospital East (NCCE) in Kashiwa, Japan, where he is the Deputy Director of Hospital, Head, Division for the Promotion of Drug and Diagnostic Development and Director for the Department of Gastrointestinal Oncology.

Dr. Yoshino has had over 300 peer-review scholar journal publications on CRC. In addition, he holds several professional appointments, serving on a Guidelines Steering Committee member of ESMO, a chair of Pan-Asian adapted ESMO Guideline for CRC, an advisory committee member of ASCO Breakthrough, the Vice President of JSCO and the administrative board & a chair of international affairs committee of JSMO. He was the first Japanese plenary speaker at ASCO 2022 Annual Meeting (5th /JUN/ 2022).

• 

  Advisor in DoMore

  Personalized medicine made simple with artificial intelligence